Geneoscopy to Join Fight CRC at the White House to Address Colorectal Cancer Screening Needs
ST. LOUIS, MISSOURI (JULY 19, 2022) | Earlier this year, President Joe Biden announced plans to reignite the Cancer Moonshot with renewed…
Geneoscopy Announces Formation of Scientific Advisory Board to Inform Strategy for the Advancement of Gastrointestinal Health
ST. LOUIS, June 21, 2022 /PRNewswire/ -- Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for…
Geneoscopy Cost-Effectiveness Modeling Data Demonstrates Potential to Reduce Colorectal Cancer Cases and Deaths in the United States with RNA-FIT Screening Test
Data at 2022 Digestive Disease Week Meeting Also Shows RNA-FIT Test to Be Cost-Effective ST. LOUIS, May 23, 2022 /PRNewswire/ -- Geneoscopy Inc.,…
Geneoscopy Tackles Healthcare Disparities in Pivotal Colorectal Cancer Clinical Trial Utilizing a Digital Recruitment Strategy
Trial Enrollment Data Presented at 2022 ASCO Gastrointestinal Cancers Symposium ST. LOUIS, Jan. 20, 2022 /PRNewswire/ -- Geneoscopy Inc., a life…
Geneoscopy Announces Positive Results of Colorectal Cancer Screening Test in Prospective, Multicenter Clinical Study
Study Results Show Diagnostic Accurately Detects Colorectal Cancer and Precancerous Adenomas With High Sensitivity ST. LOUIS--(BUSINESS…
Geneoscopy Closes $105M in Financing to Advance its Noninvasive Multifactor RNA Screening Test for Colorectal Cancer Prevention
Funding to support U.S. CRC-PREVENT pivotal trial, scale commercial infrastructure, and expand diagnostic product pipeline ST. LOUIS, Nov.…
Geneoscopy Appoints Dr. Haytham Gareer as Chief Medical Officer
Seasoned medical affairs executive to advance company's diagnostics product pipeline ST. LOUIS, Mo., Oct. 18, 2021 /PRNewswire/ -- Geneoscopy…
Geneoscopy Honored by Goldman Sachs for Entrepreneurship
Andrew Barnell, CEO, Among 100 Most Intriguing Entrepreneurs at 2021 Builders + Innovators Summit ST. LOUIS, Oct. 13, 2021 /PRNewswire/ –…
Geneoscopy Enrolls First Patients in CRC-PREVENT U.S. Pivotal Trial
Clinical Trial Investigates Company's Noninvasive Multifactor RNA Screening Test for Colorectal Cancer Prevention ST. LOUIS, July 12, 2021…